Apoptosis or programmed cell death is a process by which cells in multicellular organisms are eliminated. This important physiological mechanism guarantees ordered tissue shaping during development and cellular homeostasis of adult organs. Cellular survival of many tissues depends on a constant supply of growth factors or hormones. The prostate is an androgen-dependent organ. Depletion of testosterone leads to rapid tissue involution due to apoptotic elimination of the glandular cells of the secretory epithelium ([@B19]). It is estimated that ∼80--90% of the epithelial cells of the prostate possess androgen receptors and depend on a constant supply of testosterone for their survival ([@B19]; [@B11]; [@B4]).

The rat ventral prostate has become a classical animal model in which apoptosis can experimentally be induced and analyzed after androgen ablation. Castration leads within a few days to apoptotic death of a large number of its androgen-sensitive epithelial cells. Thus, this system offers the possibility to study the biochemical events of apoptosis under physiological conditions. In view of the increasing incidence of malignancies of this organ, this model is also of paramount importance since the most effective treatment of carcinomas of the prostate is androgen ablation by castration or antiandrogen treatment. Under in vivo conditions, apoptotic cell death is always accompanied by internucleosomal DNA degradation that in many instances can be demonstrated by agarose gel electrophoresis of extracted DNA (DNA ladder formation). Thus, internucleosomal chromatin degradation has been shown to occur in the rat ventral prostate after castration ([@B20]). The exact function of chromatin fragmentation is still unclear, but it has been proposed that it represents the irreversible step of apoptosis and/or facilitates removal of the apoptotic cell. In some instances it might also lead to the destruction of viral infectious DNA or chromatin containing deleterious alterations, guaranteeing genomic stability of the organism ([@B37]). Surprisingly, it has been reported that chromatin degradation does not occur in a number of in vitro systems (established tumor cell lines), although these cells exhibit apoptotic morphological alterations ([@B32]; [@B33]). These cellular systems may, however, represent special cases in which the apoptotic pathway has become faulty either during the initial transformation or when establishing as a permanent cell line. Therefore, it remains of essential importance for our understanding of the biochemical and regulatory mechanisms of the execution of apoptosis to identify the endonuclease(s) involved in this step of the apoptotic pathway.

A number of candidate endonucleases have been proposed ([@B8]; [@B5]). Recently, Peitsch et al. (1992, 1993) presented evidence that in rat thymo- and lymphocytes, the apoptotic endonuclease is identical or very closely related to deoxyribonuclease I (DNase I).^1^ In the past, DNase I has generally been regarded as a secretory enzyme released from the pancreas and/or parotid gland ([@B43]; [@B28]) into the alimentary tract to fulfill digestive functions. However, recent reverse transcriptase--PCR data have shown that DNase I is also expressed in a number of nonsecretory rat tissues and may even be a ubiquitous protein ([@B41]). Particularly high expression of DNase I was observed in tissues with high cellular turnover containing terminally differentiating cells prone to elimination by apoptosis, like the enterocytes of the small intestine or the keratinocytes of squamous stratified epithelia ([@B41]).

Our data demonstrate that in the rat ventral prostate, the expression of DNase I is upregulated at the translational level in the glandular cells destined for apoptosis after castration. The increased DNase I expression is accompanied by the accumulation of DNase I within these cells, followed by its transfer into the cell nucleus. Furthermore, data are presented indicating that the nuclear relocation of DNase I parallels the appearance of cells of apoptotic morphology and the induction of DNA fragmentation.

Materials and Methods
=====================

Materials
---------

Bovine pancreatic DNase I was a commercial product from Worthington Biochemical Corp. (Freehold, NJ). Calf thymus DNA was obtained from Sigma (Munich, Germany). Terminal transferase was a commercial product of Boehringer Mannheim (Mannheim, Germany). Avian myeloma virus reverse transcriptase was obtained from United States Biochemicals (Cleveland, OH). Fluorescein (FITC)-labeled dUTP and dATP were purchased from Dupont/NEN (Bad Homburg, Germany) and Boehringer Mannheim, respectively. Protein A immobilized to Sepharose was obtained from Pharmacia, (Freiburg, Germany). All other reagents were of analytical grade.

Castration of Male Wistar Rats
------------------------------

Young adult male Wistar rats (250--300 g body weight) were purchased from Ivanovas (Kisslegg, Germany). The animals were kept in cages and fed Altromin rat chow and drinking water ad libidum. Castration of anesthetized animals was performed via a scrotal approach as described previously ([@B3]). After the time intervals indicated the animals were anesthetized and bled. The ventral prostates were excised as quickly as possible, washed with PBS, and stored at −80°C until use. For the preparation of tissue homogenates, the washed ventral prostates were homogenized in 50 mM potassium phosphate, pH 6.5, supplemented with 0.25 mM PMSF and 2,000 U aprotinin/ml. After centrifugation at 20,000 *g* for 15 min, the proteins of the supernatants were precipitated with ammonium sulfate (final concentration 85%) and centrifuged again at 20,000 *g* for 30 min. The precipitate was dissolved in 20 mM potassium phosphate, pH 6.5, and dialyzed overnight at 4°C against the same buffer. The obtained material was used directly for determination of endonucleolytic activity or further purified by preparative gel electrophoresis.

Preparative Procedures
----------------------

Commercial bovine pancreatic DNase I (EC 3.1.21.1) was further purified as described by [@B26]. Rat parotid DNase I was isolated and purified as given by [@B17]. Bovine DNase I was immobilized on vinylsulphone agarose (Mini-Leak; KEM EN TEC, Copenhagen, Denmark). Rabbit skeletal muscle actin was prepared as given by [@B26]. Human gelsolin segment 1 was expressed by transformed bacteria and isolated as detailed in [@B48]. The stoichiometric 1:1 complex of segment 1 and monomeric (G-)actin was obtained by mixing both proteins at equimolar ratio.

The specificity of the polyclonal antibodies against either bovine or rat DNase I has been described previously ([@B27]; [@B17]). They were further affinity purified as detailed by [@B39] and tested by Western blotting for monospecificity using rat parotid homogenate (not shown, but see [@B17]). For immunoabsorption experiments, 50 μl of the affinity-purified polyclonal anti--rat DNase I antibody (2 mg/ml IgG) was incubated with 100 μl protein A--Sepharose for 2 h at room temperature and subsequently washed twice with 100 mM Tris-HCl, pH 8.0, following the protocol given in [@B13]. For immunoabsorption, 100 μg of the tissue homogenates were incubated with 50 μl of anti--DNase I bound to protein A--Sepharose. After 2 h of incubation at room temperature, the mixture was centrifuged for 10 min at 1,000 rpm. The supernatants were analyzed for endonucleolytic activity using the plasmid degradation assay (10 μl of supernatant containing 5 μg of protein) or incubating 80 μl of supernatant (40 μg protein) with 2 × 10^5^ isolated substrate nuclei prepared from mycoplasma-free cells of the human mammary carcinoma MCF-7 line ([@B33]; [@B34]). For controls, the samples were identically treated using unloaded protein A--Sepharose.

Analytical Procedures
---------------------

Protein concentration of purified DNase I was determined either by absorbance measurement at 280 nm using an extinction coefficient of 1.23 cm^−1^ and mg^−1^ for the bovine enzyme or by the [@B6] procedure for rat parotid DNase I. DNase I activity was tested either by the hyperchromicity test initially introduced by [@B18], by the radial diffusion test using 1% agarose gels soaked with 50 μg salmon sperm DNA/ ml as detailed by [@B31], or the plasmid degradation assay ([@B35], 1993). DNA ladder formation was analyzed by agarose gel electrophoresis as given by [@B34].

Plasmid Degradation Assay
-------------------------

The presence of endonucleolytic activity in tissue homogenates was verified by measuring the time-dependent degradation of the circular plasmid pBluescript II KS(+) or pUC 18 ([@B35], 1993). The reaction mixture (30 μl total volume) contained 0.5 μg plasmid in 20 mM Tris-acetate, pH 7.4, 2 mM CaCl~2~, and 2 mM MgCl~2~ and was supplemented with either 20 mM EDTA, 20 mM EGTA, or 5 mM ZnCl~2~. Samples of tissue homogenates of ventral prostates and parotid gland containing 5 and 0.5 μg of protein, respectively, were added to start the reaction. After 90 min, the reaction was stopped by adding sample buffer for agarose gel electrophoresis (0.25% bromophenol blue, 0.25% xylene cyanol, 30% glycerol, 50% formamide, 1 mM EDTA, and 20 mM MOPS). Fractions from the Prep Cell preparation (see below) were analyzed in identical buffer supplemented with 1% BSA to absorb the SDS present in the elution buffer and to facilitate renaturation of the endonuclease. The samples were incubated for 16 h at 37°C.

Dot and Northern Blotting and RNase Protection Assay
----------------------------------------------------

Total RNA from rat ventral prostates was prepared according to [@B9]. Dot and Northern blots were performed as described previously ([@B49]; [@B41]) using as probe the cDNA of rat parotid DNase I ([@B38]). For the RNase protection assay, an antisense RNA was transcribed from a gel-purified AvaII fragment of the DNaseI cDNA cloned in pBluescript II KS(+) vector using T3-RNA polymerase (Stratagene, La Jolla, CA) and \[^32^P\]CTP. The unprotected labeled RNA fragment was 651 bp, and the protected was 587-bp long. RNA protection analysis with total RNA of the rat parotid and prostate glands was performed using the ribonuclease protection analysis kit II from Ambion (Austin, TX) following the instructions given in the manual. Protected fragments were analyzed on a 5% polyacrylamide/ 8 M urea gel and detected on x-ray film (X-AR; Kodak, Inc., Rochester, NY) after overnight exposure at −80°C using an intensifying screen.

Electrophoretic Procedures
--------------------------

Electrophoresis on polyacrylamide (PAA) gels in the presence of sodium dodecylsulfate (SDS-PAGE) was performed as given by [@B22]. Silver nitrate staining of PAA gels was carried out following the protocol of Merril (1981). To probe the presence of nucleases of protein samples or tissue homogenates, zymograms were performed on SDS gels saturated with 10 μg/ml calf thymus DNA as given by [@B21]. To successfully detect endonucleolytic activity within tissue homogenates of ventral prostates, it was found essential to use sample buffer free of disulfide reducing reagents like DTE or β-mercaptoethanol. It is known that these reagents inhibit the renaturation process of DNase I by preventing the formation of the essential disulfide bridge of DNase I ([@B28]). This result might therefore also be taken as additional evidence for the presence of this endonuclease in the prostatic homogenates.

Alternatively to the standard zymogram technique, we established a new technique in which the native blue gel procedure (Schägger and von Jagow, 1991; [@B45]) was combined with an agarose overlay technique to avoid SDS treatment and boiling. This technique allowed the visualization of small amounts of endonuclease activity that were not detected using the standard zymogram technique. Tissue homogenates were solubilized by addition of 750 mM 6-aminocaproic acid, 50 mM Bistris, pH 7.0, and separated in a gradient gel (5--20% PAA) with 50 mM Tricine, 15 mM Bistris/HCl, pH 7.0, 0.005% Coomassie brilliant blue as cathode buffer, and 50 mM Bistris/HCl, pH 7.0, as anode buffer (Schägger and von Jagow, 1991; [@B45]). The gels were placed overnight at 37°C on agarose gels containing 10 μg/ml DNA, 5 mM MgCl~2~ and CaCl~2~ and ethidium bromide in 50 mM cacodylate buffer, pH 6.5, according to [@B31]. Then the agarose gels were washed in reactivation buffer (40 mM Tris/HCl, 5 mM CaCl~2~, 5 mM MgCl~2~, pH 7.5) at room temperature until dark bands of nuclease activity could be seen under UV illumination.

For preparative gel electrophoresis in the presence of SDS, a Prep Cell (Biorad, Munich, Germany) was used employing a 10% polyacrylamide gel for protein separation. Prostate homogenates prepared as described above and containing 10 mg protein were treated with sample buffer at room temperature, loaded on the gel, and eluted as detailed by the manufacturer. Fractions of 1.8 ml were collected and immediately frozen and stored at −20°C until use.

Western blotting was performed after electrophoretic transfer on nitrocellulose membranes (BA 83 membranes; Schleicher and Schuell, Dassel, Germany) as detailed previously ([@B10]). For immunoblotting, we raised a polyclonal antibody in rabbits that was generated against SDS-denatured DNase I. To this aim, purified rat parotid DNase I was subjected to SDS-PAGE and subsequently electroblotted onto nitrocellulose membrane. The transferred DNase I was briefly stained, and the blotted band was excised, dissolved in DMSO, and used as antigen. For densitometry we used the INTAS (Göttingen, Germany) gel documentation system equipped with the CREAM quantifying program supplied by KEM EN TEC.

In Situ Hybridization
---------------------

To generate DNase I--specific antisense and sense probes, the 334-bp HindIII fragment of rat parotid DNase I--specific cDNA (corresponding to positions 650--984 of the nucleotide sequence of rat parotid DNase I according to Polzar and Mannherz (1990; these sequence data are available from GenBank/EMBL/DDBJ under accession number X56060) was subcloned into pBluescript II KS(+) vector (Stratagene). To obtain the antisense probe, the plasmid was linearized with XbaI followed by transcription using T3-RNA polymerase; to generate the sense probe, the plasmid was linearized with HindIII and transcribed using T7-RNA polymerase ([@B54]). The RNA transcripts were labeled with fluorescein-UTP (RNA Detection Kit; Amersham Buchler GmbH, Braunschweig, Germany).

For in situ hybridization, small slices of ventral prostates were immediately fixed in 4% buffered paraformaldehyde after sacrificing the animal. After fixation, the tissues were paraffin embedded. Sections of 5 μm were cut, mounted on silanated slides, deparaffinized in xylene, and rehydrated according to standard procedures. After successive treatment with 0.02 M HCl for 10 min and 0.1% Triton X-100 in PBS for 90 s and washing in PBS twice for 3 min, the specimens were digested with 100 μg/ml proteinase K for 4 min, treated with 2 μg/ml glycine for 5 min, followed by 20% acetic acid for 15 s. Hybridization was done in hybridization buffer containing 50% formamide with 500 ng probe/ml at 55°C overnight. Specimens were washed with 1× SSC, 0.1% SDS (twice for 5 min at room temperature) and 0.2× SSC, 0.1% SDS (twice for 10 min at 55°C). Then the slides were incubated overnight with antifluorescein antibody tagged on alkaline phosphatase (RNA Detection Kit; Amersham Buchler GmbH). Visualization of bound alkaline phosphatase was achieved by using 5-bromo-4-chloro-3indolyl phosphate and Nitro blue tetrazolium chloride as substrates following exactly the protocol given by the supplier. All solutions and glassware used for in situ hybridization were autoclaved or baked at 200°C to inactivate RNase activities.

Histochemical Procedures
------------------------

Fresh tissues were fixed with 4% formaldehyde and embedded in paraffin, and 5-μm-thick sections were spread on poly-[l]{.smallcaps}-lysine--coated slides. For immunohistochemistry, endogenous peroxidase was inactivated by 3% H~2~O~2~/methanol for 30 min at −20°C. After rehydration, the tissue sections were immersed in PBS for 5 min and then blocked with 10% goat serum for 30 min. Thereafter, they were incubated overnight (about 16 h) with an affinity-purified polyclonal primary antibody against rat parotid DNase I ([@B17]; [@B36]; [@B41]) in a humid atmosphere at room temperature. The staining with streptavidin peroxidase/DAB was done according to the instructions of the manufacturer (DAKO, Hamburg, Germany). Control experiments were performed after affinity absorption of the antibody preparations onto immobilized bovine DNase I. In all instances this treatment led to a complete suppression of the specific immunoreaction.

In situ end-labeling (ISEL) of free 3′-OH ends of fragmented chromatin of paraffin-embedded sections was performed as described previously ([@B12]; [@B50]) with the modifications given by [@B41] using FITC-labeled dATP or dUTP at 40 μM as substrate for the terminal deoxynucleotidyl transferase.

Photographs were taken (HP5 film; Ilford, Mobberley Cheshire, UK or Ektachrome 400HC film; Kodak, Inc., Rochester, NY) using a microscope (model Axioskop; Carl Zeiss, Jena, Germany) equipped with epifluorescence optics.

Results
=======

Time-dependent Weight Decrease of the Ventral Prostate after Castration
-----------------------------------------------------------------------

In agreement with previous data ([@B20]), we found that the wet weight of the rat ventral prostate continuously decreased to about one fifth of its control value within the first 7 d after castration. Histological analysis showed a considerable reduction in the height of the secretory epithelium and the size of the secretory follicles at days 5 and 7 (see Fig. [2](#F2){ref-type="fig"}, *e* and *f*). In this study, we only used the ventral prostate, which was previously shown to be most affected by androgen withdrawal ([@B20]; [@B11]; [@B4]).

In Situ End-labeling of Apoptotic Cells
---------------------------------------

Cells containing fragmented DNA can be identified by in situ end-labeling of the free 3′-OH ends generated during the internucleosomal DNA-degradation using labeled dUTP and terminal deoxynucleotidyl transferase ([@B12]; [@B50]; [@B41]). Applying this technique on sections of rat prostate at different time intervals after castration, we found that the number of labeled cells increased up to day 3 (Fig. [1](#F1){ref-type="fig"}, *b--e*) in agreement with previous quantitative data showing that most of the cells are eliminated between day 3 and 5 ([@B20]; [@B2]; [@B4]; [@B47]). The strongly stained nuclei were of varying size (Fig. [1](#F1){ref-type="fig"} *d*) or fragmented (Fig. [1](#F1){ref-type="fig"} *c*). The fate of the apoptotic cells seemed to differ: In many instances, we observed positively end-labeled cells located underneath epithelial cells of normal appearance (Fig. [1](#F1){ref-type="fig"} *d*). In some cases, the apoptotic cells were found to be extruded into the lumenal space (see also Fig. [3](#F3){ref-type="fig"} *b*).

Immunohistochemistry Using Anti--DNase I
----------------------------------------

We have recently presented evidence that the apoptotic Ca^2+^,Mg^2+^-dependent endonuclease is identical or very similar to DNase I ([@B35], 1993). Therefore, the expression and distribution of DNase I in rat ventral prostate was analyzed before and after castration using polyclonal, affinity-purified antibodies ([@B17]; [@B41]). In control organs, most of the epithelial cells were DNase I negative. In some instances, we detected a weak immunostaining located in the apical region of the epithelial cells (not shown). Occasionally, single cells with an apparently apoptotic morphology exhibited strong nuclear DNase I immunoreactivity (Fig. [2](#F2){ref-type="fig"} *a*). 6 h after castration, a number of cells exhibited increased cytoplasmic DNase I immunoreactivity, although the number of presumed apoptotic cells with positive nuclear staining was not increased (Fig. [2](#F2){ref-type="fig"} *b*). 12 h after castration, a clear increase in DNase I immunoreactivity already became detectable in the apical region of many epithelial cells (Fig. [2](#F2){ref-type="fig"} *c*). It was often found to be clustered in a given region of a particular follicle (not shown). The staining intensity of this cytoplasmic location increased during the following 2 d. At day 3, the DNase I antigenicity was clearly increased. It was only present in the columnar epithelial cells (Fig. [2](#F2){ref-type="fig"} *d*). It appeared as granular apical staining, i.e., in regions known to harbor the endoplasmic reticulum and the Golgi apparatus. In addition, an increasing number of nuclei were DNase I positive (Fig. [2](#F2){ref-type="fig"} *d*). At days 5 and 7, most of the nuclei of the epithelial cells were DNase I positive (Fig. [2](#F2){ref-type="fig"}, *e* and *f*). The diameter of the secretory follicles and the height of their epithelium were found to be significantly reduced (Fig. [2](#F2){ref-type="fig"}, *e* and *f*), and the alveoli frequently exhibited epithelial infoldings (Fig. [2](#F2){ref-type="fig"} *f*). At day 7, a large number of the remaining epithelial cells still exhibited nuclear DNase I immunoreactivity, although a considerable number of cells were DNase I negative (Fig. [2](#F2){ref-type="fig"} *f*). At day 3, we detected the highest number of cells showing apoptotic morphology (Fig. [3](#F3){ref-type="fig"}, *a--d*). Cells containing fragmented nuclei or apoptotic bodies were frequently detected in epithelial infoldings and shown to be DNase I positive (Fig. [3](#F3){ref-type="fig"}, *a*, *c*, and *d*). A few apoptotic cells with apparently less nuclear remnants were DNase I negative (Fig. [3](#F3){ref-type="fig"} *d*). Most of the apoptotic cells were localized at the basal site of the epithelium, although in some instances we detected apoptotic cells that were apparently shed into the lumenal space (Fig. [3](#F3){ref-type="fig"} *b*).

Localization of DNase I Gene Transcripts by In Situ Hybridization
-----------------------------------------------------------------

In situ hybridization using DNase I--specific antisense and sense RNA was used to localize its gene transcripts and to analyze its time-dependent variation after castration. Sections of the ventral prostate before and after castration were stained using sense and antisense probes. The sense probe did not show any labeling at all when used on sections of control prostates and at any other time point after androgen ablation (Fig. [4](#F4){ref-type="fig"} *a*). In control prostates, a specific staining (blue stain) of exclusively epithelial cells was obtained using the antisense probe (Fig. [4](#F4){ref-type="fig"}, *b* and *c*). Within the epithelial cells, the staining was most prominent at supranuclear and apical localization that was frequently found to be interrupted by a narrow unstained region (Fig. [4](#F4){ref-type="fig"}, *c* and *d*). From ultrastructural studies, it is known that the rough endoplasmic reticulum is interrupted and localized in supranuclear and apical positions (Aumüller at al., 1980). Using the antisense probe, the homogeneous staining of the epithelial cells remained until day 2 (Fig. [4](#F4){ref-type="fig"} *d*). At day 3, a considerable number of apoptotic cells were detected whose fragmented nuclei were in many instances strongly labeled (Fig. [4](#F4){ref-type="fig"}, *e* and *f*, black stain). The intensity of the specific stain decreased at day 5 (Fig. [4](#F4){ref-type="fig"} *g*) and was further reduced at day 7 (not shown).

Analysis of DNase I--specific Gene Transcripts
----------------------------------------------

The results obtained by in situ hybridization indicated the presence of DNase I gene transcripts in rat ventral prostates even before castration. Total RNA was isolated from ventral prostates before and at different time points after castration. Using the cDNA of rat parotid DNase I as probe on dot blots of total RNA of control and day 1, 3, and 5 prostates, the presence of DNase I gene transcripts was verified (Fig. [5](#F5){ref-type="fig"} *a*). Similar results were obtained by Northern blotting (Fig. [5](#F5){ref-type="fig"} *c*). One single mRNA band was obtained for days 0, 1, 3, and 5 that was identical in length to the one present in rat parotid RNA (1, 1 kb). Both assays indicated a slight decrease in the concentration of the DNase I--specific gene transcripts after androgen withdrawal. Furthermore, RNase protection analysis was used to attempt a more reliable, relative quantification of the DNase I gene transcript using total prostatic RNA (see Materials and Methods). A DNase I--specific signal was obtained for rat prostate that was identical in size to the one for rat parotid gland, although with an ∼20-fold lower intensity (Fig. [5](#F5){ref-type="fig"} *d*). Again, a clear decrease in the concentration of DNase I gene transcript was seen during the 5 d after castration.

Analysis of DNase I Specific Activity
-------------------------------------

Using the zymogram technique ([@B21]) with the modifications described in Materials and Methods, endonucleolytic activities were detected in prostatic tissue homogenates before and after castration (Fig. [6](#F6){ref-type="fig"} *a*). This procedure also allowed us to determine the molecular mass of the endonuclease(s) and to estimate changes of its activity after castration. Control prostates contained a single endonucleolytic entity of 32 kD and low activity (Fig. [6](#F6){ref-type="fig"} *a*). After castration at day 1, three endonucleolytic entities of higher molecular mass were detected. However, at day 3 the pattern seemed to revert to the original one with a high activity of ∼32 kD and minor activities of higher molecular mass, whereas at day 5 only very little activity of 32 kD was detected. Densitometry of the gel revealed that the total activity had increased about sevenfold at day 3 (Fig. [6](#F6){ref-type="fig"} *b*). The molecular mass of the endonucleolytic activity in control animals and at day 5 was ∼32 kD, almost identical to that of purified rat parotid DNase I or the activity present in rat parotid homogenate. This pattern of endonuclease isoforms was observed repeatedly using different animals (*n* = 6), and we assume that the shifts of apparent molecular mass at day 1 are due to increased synthesis of proforms that are processed during the following days. This analysis indicates the presence of at least four different isoforms: three at day 1 in addition to the 32-kD isoform. At day 3, the 32-kD variant predominates, although the ones with higher molecular mass were still visible. Even at day 5, isoforms of molecular mass greater than 32 kD were still detectable on the original gel. The endonucleolytic activity of all entities was inhibited by addition of either 20 mM EDTA, 20 mM EGTA, or 5 mM ZnCl~2~ into the reactivation buffer (not shown), indicating identical enzymatic properties.

The zymogram technique necessitates heating and denaturation steps to prepare the samples for SDS-PAGE, which could have led to an at least partial irreversible inactivation of the endonuclease(s). Therefore, we developed a modified zymogram procedure using native blue gel electrophoresis (Schägger and von Jagow, 1991; [@B45]) to verify the observed changes in relative activity after castration. As described in Materials and Methods, samples of homogenates of prostates before and after castration were first subjected to nondenaturing gel electrophoresis. Thereafter, the gel was placed on a 1% agarose gel containing calf thymus DNA and ethidium bromide. After diffusion of the separated proteins, the agarose was incubated in 40 mM Tris-HCl, pH 7.5, 5 mM CaCl~2~, and 5 mM MgCl~2~, and the location of DNA degrading activities was identified by UV light (as detailed in Materials and Methods). A single, broad band of endonucleolytic activity was detected in all homogenates that exhibited a migration behavior identical to the endonucleolytic activity present in rat parotid gland (Fig. [6](#F6){ref-type="fig"} *c*) or purified rat parotid DNase I (not shown). It was also evident that after castration, the activity present in prostatic homogenates exhibited the identical time course, i.e., increasing up to day 3 followed by a considerable decrease at day 5. The densitometric analysis of these gels indicated a similar time-dependent quantitative increase of the endonucleolytic activity (Fig. [6](#F6){ref-type="fig"} *d*). Using this technique, we also analyzed the pH dependence of the endonucleolytic activities present in homogenates from days 0, 1, 3, and 5. In the range of pH 6 to 9, we observed only one nucleolytic activity comigrating with DNase I that was inhibited by Zn^2+^ ions, EDTA, or EGTA (not shown). At pH 5.5, an additional band appeared that comigrated with commercial DNase II and was not inhibited by Zn^2+^ ions, EDTA, or EGTA (not shown).

The difference in endonucleolytic activity between control and day 3 prostates was also verified using the plasmid degradation assay ([@B35], 1993). A sequential dilution analysis of the tissue homogenates revealed that a 1:2 and 1:8 dilution diminishes the endonucleolytic activity present in day 0 and 3 prostates, respectively, to a similar extent (almost no degradation), indicating an at least fourfold higher activity in day 3 prostate in reasonable agreement with the densitometric analyses (Fig. [6](#F6){ref-type="fig"} *e*).

Specific Tests for the Presence of DNase I in Rat Prostate Homogenates
----------------------------------------------------------------------

A number of specific tests for DNase I were performed comparing prostatic homogenates (5 μg) of day 0 and 3. Using the plasmid degradation assay, the ionic requirements of the prostatic endonuclease were further investigated (Fig. [7](#F7){ref-type="fig"} *a*). It can be seen that the endonucleolytic activity present in the homogenate of control and day 3 prostates was active in the presence of 2 mM CaCl~2~ and 2 mM MgCl~2~ but completely inhibited after addition of 5 mM ZnCl~2~, 20 mM EDTA, or 20 mM EGTA. This ion dependence parallels the known behavior of the Ca^2+^, Mg^2+^-dependent apoptotic endonuclease or DNase I.

DNase I is the only endonuclease whose enzymatic activity is specifically inhibited by monomeric (G-) actin ([@B23]; [@B25]; [@B14]). Since actin polymerizes at high ionic strength and loses its ability to inhibit rat DNase I ([@B17]), G-actin was complexed with gelsolin segment 1, which stabilizes actin in its monomeric form even in the presence of high salt without interfering with DNase I binding ([@B15]; [@B29]). Thus, stabilized monomeric actin was found to inhibit the endonuclease activity present in control and day 3 prostatic homogenates as determined by the plasmid degradation assay (Fig. [7](#F7){ref-type="fig"} *b*). It was found that higher amounts of actin:segment 1 complex were necessary to attain complete inhibition of the endonucleolytic activity present in day 3 homogenate (Fig. [7](#F7){ref-type="fig"} *b*).

Furthermore, the polyclonal, affinity-purified antibody was immobilized to protein A--Sepharose and used for immunoabsorption. The endonuclease present in day 0 and 3 homogenates was almost completely depleted after preincubation with immobilized anti--DNase I, as verified by analyzing the Sepharose supernatants by using the plasmid assay (Fig. [7](#F7){ref-type="fig"} *c*). We also tested the ability of the prostatic homogenates to catalyze the internucleosomal chromatin degradation of endonuclease-free substrate nuclei (prepared from mycoplasma-free MCF-7 cells). It can be seen that day 3 homogenate induces a typical DNA ladder (Fig. [7](#F7){ref-type="fig"} *d*, lanes *7* and *8*). After immunoabsorption using the protein A--immobilized DNase I antibody, DNA ladder formation was completely suppressed (Fig. [7](#F7){ref-type="fig"} *d*, lane *9*), indicating that the endonucleolytic activity immunodepleted from day 3 homogenate is the enzymatic entity able to catalyze the internucleosomal chromatin degradation.

In contrast, day 0 homogenate (Fig. [7](#F7){ref-type="fig"} *d*, lanes *4--6*) was not able to induce DNA ladder formation under identical incubation conditions. It is presently unclear whether this inability is due to its lower concentration or to the presence of modifications of the DNase I of day 0 homogenate or to specific inhibitors. Day 0 homogenate catalyzes chromatin degradation to high--molecular mass fragments that are just able to migrate into the agarose gel ([@B32]). This activity is not precipitated by the anti-- DNase I antibody (Fig. [7](#F7){ref-type="fig"} *d*, lanes *6* and *9*). It cannot be excluded that after immunoprecipitation, the endonucleolytic activity of possibly residual DNase I was too low for producing a DNA ladder, although the result may also suggest that two different enzymatic entities are responsible for the production of the high--molecular mass fragments and the internucleosomal DNA degradation. Future experiments will concentrate on these questions.

Identification of DNase I by Western Blotting
---------------------------------------------

Using the affinity-purified polyclonal antibody, attempts were made to identify DNase I in prostate homogenates by Western blotting. Most probably because of the low abundance of this enzyme, no positive reaction was obtained when using whole tissue homogenates. Therefore, the endonucleolytic activity was partially purified and enriched from tissue homogenates of control and day 3 prostates by preparative SDS-PAGE applying 10 mg of protein. The fractions collected were analyzed for endonuclease activity by the plasmid degradation assay (Fig. [8](#F8){ref-type="fig"}, *a* and *b*). Analysis of the activity containing fractions by SDSPAGE indicated a molecular mass range between 32 and 35 kD (Fig. [9](#F9){ref-type="fig"}, *a* and *c*) in agreement with the zymogram analysis. These fractions most probably represent a mixture of different prostatic proteins of this molecular mass range. Fractions containing the highest endonucleolytic activity of control and day 3 eluate were subjected to SDSPAGE followed by standard Western blotting. A band of ∼32 kD apparent molecular mass was stained by the polyclonal, affinity-purified antibody (Fig. [9](#F9){ref-type="fig"}, *b* and *d*). A much stronger immunoreaction was observed for the day 3 fraction. Densitometry indicated a fivefold increase in intensity at day 3 using the constant amount of purified rat parotid DNase I applied as internal standard (not shown). In agreement with the histochemical data, this result indicates that the amount of DNase I gene product was increased in day 3 homogenate. No staining was observed of fractions void of endonucleolytic activity (Fig. [9](#F9){ref-type="fig"}, *b* and *d* lanes *0*′ and *3*′). In this experiment we used purified rat parotid DNase I as control, which for unknown reasons always gave a higher apparent molecular mass (∼33 kD) than when present in whole tissue extracts (see also Fig. [6](#F6){ref-type="fig"}).

Discussion
==========

The induction of apoptotic elimination of prostate epithelial cells after testosterone withdrawal represents a wellestablished in vivo model system for the analysis of the biochemical and molecular mechanisms of programmed cell death ([@B20]; [@B11]). It is estimated that ∼80% of the epithelial cells of the rat ventral prostate are eliminated after castration. Recent data ([@B20]) demonstrated that internucleosomal chromatin degradation (DNA ladder formation) becomes first detectable at day 1, and DNA degradation reaches its maximum at days 3 and 4 after castration. These authors attributed the DNA fragmentation to the parallel activation of a Ca^2+^,Mg^2+^-dependent endonucleolytic activity. The exact nature of this endonucleolytic activity has remained elusive so far. Here we present evidence at the level of specific mRNA and protein that DNase I is expressed in the rat ventral prostate. The zymogram data demonstrate that at neutral pH, one endonucleolytic entity is present in rat ventral prostate whose activity increases considerably after castration up to day 3. The prostatic endonuclease possesses ionic requirements identical to DNase I, i.e., activation by Ca^2+^ and Mg^2+^ ions and complete inhibition by Zn^2+^ ions or chelators of divalent cations. Its molecular mass and mobility was similar to DNase I as verified by the zymogram technique and native blue gel electrophoresis, respectively. Like DNase I, it is inhibited by monomeric actin. Its identity to DNase I is further supported by the observed immunological crossreactivity (Western blot and immunoabsorption) and the ability of DNase I--specific RNA probes to hybridize under stringent conditions to gene transcripts present in rat ventral prostate.

A DNase II--like enzyme was only detected at pH 5.5. Because of its independence on Ca^2+^ and Mg^2+^ ions, we believe that it is not involved in the internucleosomal DNA degradation (see also [@B20]). In contrast to DNase I, which generates 3′-OH oligonucleotides, DNase II produces 5′-OH DNA fragments. 5′-OH ends are not labeled by the ISEL technique. We cannot, however, completely exclude the possibility that other endonucleases might participate in the apoptotic DNA fragmentation. Since, however, we were unable to detect endonucleolytic activities different from DNase I at neutral pH, we feel confident that DNase I is at least one candidate for the Ca^2+^,Mg^2+^-dependent endonuclease(s) responsible for the chromatin degradation during apoptosis of these cells. It will be necessary to await similar histochemical and enzymatic analyses using specific probes for other candidate endonucleases ([@B8]; [@B5]).

The enzymatic analysis (zymograms and plasmid assays) and Western blots indicated that the endonucleolytic activity is considerably upregulated after castration at day 3. Our data obtained from immunohistochemistry demonstrate a significant increase of DNase I antigenicity after castration, which was exclusively localized in the prostatic epithelial cells. DNase I antigenicity was only rarely detected in control animals. In contrast, the data obtained by in situ hybridization demonstrate that even under control conditions, prostatic epithelial cells express DNase I gene transcripts, whose concentration was shown to slightly decrease after castration by dot and Northern blots as well as RNase protection. In situ hybridization indicates that DNase I--specific mRNA is localized within the cytoplasm of all prostatic epithelial cells before androgen ablation. After castration, however, the DNase I gene transcripts were found to be particularly concentrated in cells undergoing apoptosis, although this might have been because of the concomitant reduction in cell volume. The overall decrease in epithelial cell mass might also explain the reduction in total DNase I--specific mRNA as observed by the RNase protection assay. Indeed, it has been reported that the level of total RNA drops faster after castration than the cell number ([@B11]). Since, however, our data also indicate no gross alteration in the gene transcript concentration of the house-keeping protein β-actin, we assume that DNase I expression is translationally upregulated after androgen withdrawal. Regulation at the translational level appears to be plausible, since: (*a*) in control animal, there is very little DNase I expression in spite of the presence of its gene transcripts in the epithelial cells; and (*b*) the increase in DNase I expression occurs well before the elevation of the rate in apoptotic cell elimination. Indeed, the DNase I gene product is considerably increased at day 3 as determined by immunohistochemistry and the biochemical procedures, when a decrease in the concentration of DNase I gene transcripts is obtained. Recently, it was demonstrated that a member of enzyme system necessary for mRNA maturation (the 70-kD U1 subunit of the snRNP-particle) is proteolytically degraded during the onset of apoptosis ([@B7]). This will lead to a decreased rate or even arrest of mRNA maturation and would necessitate the regulation of the expression of proteins needed for the execution of apoptosis at the level of translation. Additional support for a translational regulation of DNase I expression comes from recent data obtained on the human mammary adenocarcinoma cell line MCF-7 that demonstrate the presence of DNase I gene transcripts in these cells, but a lack of expression of the mature protein even after conditions supposed to induce apoptosis-like treatment with the antiestrogen tamoxifen ([@B33]).

In the past, DNase I has only been regarded to be a secretory enzyme, although a number of data indicate that it is ubiquitously expressed ([@B24]; [@B41]). Its cDNA cloned from rat parotid contains a signal sequence ([@B38]). Indeed, under control conditions, DNase I antigenicity was sometimes observed in prostatic secretion, and enzymatic analysis demonstrated the presence of low activity in the secretory product of control prostates (data not shown). The mechanism of its intracellular accumulation is presently not fully understood. It is possible that the alterations and collapse of the cytoskeleton during apoptosis arrests the normal exocytotic pathway and leads to the retention of the increasingly expressed DNase I. It would then be intracellularly accumulated and finally be relocated into the cell nucleus. This intracellular routing has already been observed after transient transfection of the cloned DNase I cDNA and its overexpression in COS cells ([@B40]). Furthermore, perinuclear localization or even storage of DNase I was demonstrated for a number of cell systems that constitutively express this endonuclease ([@B36], 1994; [@B28]). Alternatively, induction of apoptosis may lead to the expression of variants of DNase I that are specifically transferred from the endoplasmic reticulum to the perinuclear space and finally into the cell nucleus. The zymograms demonstrated the appearance of three endonucleolytic bands of increased apparent molecular mass at day 1. Since we observed only a single form of DNase I transcript by Northern blots, this may indicate the formation of unprocessed preforms during the time period of increased translation. In addition, the existence of a number of DNase I variants possessing different apparent molecular masses because of differences in glycosylation is well documented ([@B17]; [@B31]; [@B53]). At day 3, the dominant band is 32 kD and of high activity. This would suggest a switch to the variant that is also normally found in other tissues ([@B41]). We tentatively assume, however, that this switch in isoform pattern is due to the maturation of newly expressed enzyme, but further experiments using in vitro translation systems will be necessary to decide this question.

The in situ end-labeling technique demonstrated that even at day 3, only a small fraction of these cells possess fragmented DNA. This indicates that like in the small intestine or stratified epithelia, the prostatic epithelial cells express DNase I in advance of their apoptotic elimination ([@B41]; [@B54]). The migration of enterocytes along the villar surface or keratinocytes within epithelia resolves their fate spatially and temporally. In these tissues, a similar intracellular relocation of the increasingly expressed DNase I was observed, namely an initial cytoplasmic, then perinuclear, and finally nuclear accumulation that could be correlated to the migration of these terminally differentiating cells towards the location of their final apoptotic elimination.

In summary, the data obtained by immunohistochemistry and in situ hybridization demonstrate a clear correlation of the intracellular accumulation of DNase I to the increase in the rate of apoptotic cell elimination and DNA fragmentation of prostatic epithelial cells after castration. Our data obtained by immunohistochemistry demonstrate the presence of DNase I in cells with apoptotic morphology. We furthermore demonstrate that DNase I also fulfills one of the main requirements for being the apoptotic endonuclease, namely its intranuclear localization. The fact that it is expressed at an elevated level and retained intracellularly only after induction of apoptosis may be part of safeguard mechanisms that prevent its untimely contact with nuclear chromatin.

Our data may also be of clinical relevance since carcinomas of the prostate occur with increasing frequency. Their successful treatment is of paramount importance. They originate in most cases from epithelial cells and initially maintain their testosterone responsiveness, i.e., testosterone ablation can lead to tumor regression most probably by apoptotic elimination. Androgen ablation is the most effective form of therapy, at least during the initial stage of prostatic cancer therapy. Therefore, it will be interesting to analyze the expression of DNase I in these tumors in response to treatment with antitestosterones or other chemotherapeutic reagents and to evaluate the prognostic value of DNase I expression.

1\. *Abbreviations used in this paper*: DNase I, deoxyribonuclease I; PAA, polyacrylamide.
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![Immunohistochemical staining of rat ventral prostate with anti--DNase I. Rat ventral prostates were treated and stained with polyclonal affinity-purified anti--DNase I as described in Materials and Methods. (*a*) Before castration: A single positively stained cell (*arrow*) can be seen within the secretory epithelium. (*b*) 6 h after castration: Again, a single positively stained cell (*arrow*) can be seen. The cytoplasm of some cells exhibits weak DNase I immunoreactivity. (*c*) 12 h after and (*d*) 3 d after castration; note that many, but not all nuclei are positively stained. (*e*) 5 d after castration; note that most nuclei are positively stained. (*f*) 7 d after castration. Here the number of positively stained nuclei is decreased; many are DNase I negative. Identical magnification for all pictures. Bar, 100 μm.](JCB.rauch2){#F2}

![In situ end-labeling of rat ventral prostate before and after castration. (*a*) Positive control of rat prostate at day 0. The section was pretreated with purified bovine pancreatic DNase I to fragment the chromatin of all nuclei. (*b--e*) In situ end-labeling after castration: (*b*) 12 h; (*c*) 24 h; (*d*) cluster of cells; and (*e*) single cell at day 3. Bars, 100 μm.](JCB.rauch1){#F1}

###### 

Immunohistochemical staining of rat ventral prostate with anti--DNase I. Top row of color plate: (*a--d*) 3 d after castration. (*a*) An epithelial infolding containing three apoptotic cells positively stained with anti--DNase I, marked by arrows. (*b*) A single apoptotic cell that is apparently extruded into the lumen. (*c* and *d*) Apoptotic cells with fragmented nuclei that are positively stained by anti-- DNase I (*arrows*). In *d*, a presumed late apoptotic cell containing only minute nuclear remnants, which are DNase I negative, is marked by an arrowhead. *a--d* were counterstained with hematoxylin. Bar, 10 μm.

###### 

In situ hybridization of rat ventral prostates using DNase I--specific sense and antisense probes. Sections were treated as given in Materials and Methods. Using the sense probe: (*a*) No staining. (*b--g*) Antisense probe. (*b* and *c*) Before; (*d*) 2 d after; (*e* and *f*) 3 d after; and (*g*) 5 d after castration. Note cytoplasmic positive reaction at supranuclear and apical position (*blue*) in (*b--d*). At day 3 (*e* and *f*), a large number of apoptotic cells are detectable that exhibit strong staining of their fragmented nuclei, (*arrows*). At day 5, most nuclei are negative; only weak cytoplasmic, supranuclear reaction is obtained. Bars, 10 μm.
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###### 

Dot and Northern blots as well as RNase protection of a radioactively labeled probe specific for rat parotid DNase I. Dot blots (*a* and *b*) using total RNA purified from day 0, 1, 3, and 5 prostates at two dilutions. (*a*) Hybridized with rat parotid DNase I--specific cDNA and (*b*) with a probe specific for β-actin. Amount of RNA applied: Upper rows, 5 μg/dot; lower rows, 1.25 μg/dot. Northern blot (*c*) using 20 μg of total RNA from day 0, 1, 3, and 5 prostates (lanes *0*, *1*, *3*, and *5*) and 5 μg total RNA from rat parotid gland (lane *P*) hybridized with the DNase I--specific cDNA. RNase protection (*d*) of a DNase I--specific probe by DNase I--specific mRNA present in the total RNA of day 0, 1, 3, and 5 prostates. Total RNA prepared from rat prostates before and after castration (100 μg each) and from rat parotid gland (5 and 1 μg) were hybridized with the labeled antisense probe as detailed in Materials and Methods. After ribonuclease treatment, the samples were run on 5% polyacrylamide/8 M urea gel and autoradiographed. Lane *0*, before; lanes *1*, *3*, and *5*, days 1, 3, and 5 after castration; lanes *P* and *P*′, RNA isolated from parotid gland, 5 μg and 1 μg, respectively, as positive control and to qualitatively compare the concentrations of DNase I--specific mRNA in prostate to parotid gland; lane *M*, 5 × 10^3^ cpm of antisense probe as standard (651 bp).
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![Enzymatic analysis of the endonucleolytic activity present in homogenates of rat parotid and ventral prostate. SDS-zymogram (*a*) on a 15% polyacrylamide gel. Lane *A*, 140 ng protein of tissue homogenate of rat parotid; lane *B*, 0.56 ng of purified rat parotid DNase I; Lanes *0d*, *1d*, *3d*, and *5d*, 100 μg of protein from tissue homogenates from rat ventral prostate from days 0, 1, 3, and 5, respectively. Numbers on left margin give molecular mass in kD. (*b*) Histogram of the densitometric evaluation of the corresponding bands of gel *a.* Native gel electrophoresis (*c*) of tissue homogenates of rat parotid containing 0.1 μg protein and of rat ventral prostate from days 0, 1, 3, and 5 containing 30 μg of protein. (*d*) Densitometric evaluation of gel *c.* Serial dilution (*e*) of the endonucleolytic activity present in day 0 and 3 homogenates using the plasmid degradation assay. Lane *1*, negative control applying 0.5 μg of Bluescript II KS(+) plasmid on its own; lanes *2--5*, day 0 undiluted containing 5 μg of protein (lane *2*), diluted 1:2 (lane *3*), 1:4 (lane *4*), and 1:8 (lane *5*); lanes *6--9*, day 3 undiluted containing 5 μg of protein (lane *6*), diluted 1:2 (lane *7*), 1:4 (lane *8*), and 1:8 (lane *9*).](JCB.rauch6){#F6}

![Specific tests for the presence of DNase I in prostate homogenates. (*a*) Ionic dependence of the endonuclease present in prostatic homogenates using the plasmid degradation assay. Lanes *1--3*, Bluescript II KS(+) plasmid (0.5 μg) in TBE in the presence of 5 mM ZnCl~2~ (lane *1*), 20 mM EDTA (lane *2*), or 20 mM EGTA (lane 3); lane *4*, 5 μg of day 0 homogenate; lane *5*, plus 5 mM ZnCl~2~; lane *6*, plus 20 mM EDTA; lane *7*, plus 20 mM EGTA; lane *8*, day 3 homogenate (5 μg) on its own. In lanes *9--11*, the day 3 homogenate was supplemented with 5 mM ZnCl~2~, 20 mM EDTA, and 20 mM EGTA, respectively. The samples were incubated for 90 min at 37°C. For details see Materials and Methods. (*b*) Inhibition of the endonuclease present in rat ventral homogenate by actin:segment 1 complex. Lane *1*, Bluescript II KS(+) plasmid on its own; lane *2*, day 0 homogenate (5 μg of protein); lane *3* plus 2 μg actin:segment 1; lane *4*, plus 8 μg actin:segment 1; lanes *5--7*, identical experiment using day 3 homogenate (5 μg of protein). Note that for day 3 homogenate, complete inhibition of endonucleolytic activity is only attained in the presence of 8 μg of actin:segment 1. (*c*) Immunodepletion of the endonucleolytic activity in day 0 and 3 homogenates by immobilized anti--DNase I (see also Materials and Methods). Lane *1*, plasmid on its own; lane *2*, day 0 using 5 μg of homogenate after preincubation with unloaded protein A--Sepharose; lane *3*, day 0 homogenate after preincubation with protein A--Sepharose loaded with antibodies against rat DNase I; lanes *4* and *5*, identical experiment using 5 μg of day 3 homogenate (for details see Materials and Methods). (*d*) Immunodepletion of DNA ladder catalyzing activity in day 0 and 3 homogenates by immobilized anti--DNase I. Lane *1*, molecular weight marker; lane *2*, 2 × 10^5^ substrate nuclei were incubated in the presence of 20 mM EDTA and (lane *3*) 5 mM CaCl~2~ and MgCl~2~ for 24 h at 37°C. Note the absence of DNA; it was impossible to pipette the highly viscous DNA clot into the gel slot indicating the absence of endogenous endonucleases. Lanes *4--6*, 40 μg of day 0 homogenate was incubated with 2 × 10^5^ substrate nuclei for 24 h at room temperature: (lane *4*) homogenate on its own, (lane *5*) after preincubation with protein A--Sepharose alone, and (lane *6*) after preincubation with protein A--Sepharose complexed with anti--DNase I. Note that high molecular mass DNA fragments are generated in all samples. Lanes *7--9*, identical experiment using day 3 homogenate. Note that after preincubation with immobilized anti--DNase I, ladder formation is suppressed (lane *9*), although high molecular weight DNA fragments are generated. Lane *1* gives phage λ treated with HindIII as molecular mass marker (from top to bottom: 23,130; 9,460; 6,557; 4,322 \[top four closely spaced bands\]; 2,200; and 2,027 bp).](JCB.rauch7){#F7}

![Partial purification of DNase I from rat ventral prostate before and after castration using preparative gel electrophoresis in the presence of SDS. (*a* and *b*) Plasmid degradation assays to localize endonucleolytic activity in fractions collected from Prep Cell. 0.25 μg of the circular pUC 18-plasmid was applied to a 1% agarose gel on its own (negative control) or after incubation for 16 h at 37°C with 1 μg of prostatic homogenate (positive control). Numbers above lanes indicate the number of fractions collected. 10 μl of each fraction was incubated with 0.25 μg of plasmid. For details see Materials and Methods. (*a*) Representative fractions collected from day 0 and (*b*) day 3 homogenate.](JCB.rauch8){#F8}

![SDS-PAGE and immunoblots of active fractions from preparative gel electrophoresis. (*a* and *c*) Silver-stained SDS-PAGE of fractions collected from the Prep Cell runs: (*a*) day 0 and (*c*) day 3. Lane *S*, prostatic homogenate (3 μg) before separation. Numbers give fractions collected from Prep Cell. 300 μl of each fraction was precipitated with 300 μl 20% trichloracetic acid, neutralized by 1 M Tris, and loaded onto a 12.5% acrylamide gel. Numbers on left margins give molecular mass in kD. (*b* and *d*) Western blot of active fractions. Lanes *P*, 15 μg of homogenate rat parotid was treated as described above and applied to a 12.5% acrylamide gel; lanes *0*, 100 μl each of fractions 36-- 47 from Prep Cell of day 0 homogenate were pooled, precipitated, and treated as described above; lanes *0*′, fractions 50--61 were treated identically; lanes *3* and *3*′, fractions 46--57 and 64--75, respectively, from Prep Cell of day 3 homogenate were treated as described. After electroblotting onto nitrocellulose, the affinity-purified polyclonal antibody raised against denatured rat parotid DNase I was used for immunostaining (see Materials and Methods).](JCB.rauch9){#F9}
